Investigation of hormone receptor genes in migraine

Neurogenetics

Volumn 6, Issue 1, 2005, Pages 17-23

  Colson, Natalie J ^a   Lea, Rod A ^a,b   Quinlan, Sharon ^a   MacMillan, John ^c   Griffiths, Lyn R ^a  

^a GRIFFITH UNIVERSITY   (Australia)

^b VICTORIA UNIVERSITY OF WELLINGTON   (New Zealand)

^c ROYAL CHILDREN'S HOSPITAL   (Australia)

Author keywords

Androgen receptor gene; Association; Migraine; Progesterone receptor gene

Indexed keywords

ANDROGEN RECEPTOR; PROGESTERONE RECEPTOR; STEROID RECEPTOR;

ALLELE; ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DISEASE ASSOCIATION; FEMALE; FOLLOW UP; GENE INSERTION; GENETIC ANALYSIS; GENETIC VARIABILITY; GENOTYPE; HIGH RISK POPULATION; HUMAN; MALE; MIGRAINE; NUCLEOTIDE REPEAT; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN PROTEIN INTERACTION;

FEMALE; GENE FREQUENCY; GENETIC PREDISPOSITION TO DISEASE; GENOTYPE; HUMANS; MALE; MIGRAINE DISORDERS; POLYMERASE CHAIN REACTION; POLYMORPHISM, GENETIC; RECEPTORS, ANDROGEN; RECEPTORS, PROGESTERONE; REFERENCE VALUES; TRINUCLEOTIDE REPEATS; VARIATION (GENETICS);

EID: 15444369324     PISSN: 13646745     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10048-004-0205-0     Document Type: Article

References (39)

1. Rasmussen BK (1999) Epidemiology and socio-economic impact of headache. Cephalalgia 19 [Suppl] 25:20-23
2. Ducros A, Tournier-Lasserve E, Bousser MG (2002) The genetics of migraine. Lancet Neurol 1:285-293
3. Headache classification committee for the International Headache Society (2004) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain, 2nd edn. Cephalgia 24 [Suppl 1]:1-60
4. Headache classification committee for the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain, 1st edn. Cephalgia 8 [Suppl 7]:1-96
5. Nyholt DR, Gillespie NG, Heath AC, et al (2004) Latent class and genetic analysis does not support migraine with aura and migraine without aura as separate entities. Genet Epidemiol 26:231-244
6. Lea RA, Dohy A, Jordan K, et al (2000) Evidence for allelic association of the dopamine beta-hydroxylase gene (DBH) with susceptibility to typical migraine. Neurogenetics 3:35-40
7. Peroutka SJ (2002) Sympathetic look at genetic basis of migraine. Headache 42:378-381
8. Couturier EG, Bomhof MA, Neven AK, et al (2003) Menstrual migraine in a representative Dutch population sample: prevalence, disability and treatment. Cephalalgia 23:302-308
9. MacGregor EA, Chia H, Vohrah RC, et al (1990) Migraine and menstruation: a pilot study. Cephalalgia 10:305-310
10. MacGregor EA (1996) "Menstrual" migraine: towards a definition. Cephalalgia 16:11-21
11. Silberstein SD, Merriam GR (2000) Physiology of the menstrual cycle. Cephalalgia 20:148-154
12. Epstein MT, Hockaday JM, Hockaday TD (1975) Migraine and reporoductive hormones throughout the menstrual cycle. Lancet 1:543-548
13. Colson NJ, Lea RA, Quinlan S, et al (2004) The estrogen receptor 1 G594A polymorphism is associated with migraine susceptibility in two independent case/control groups. Neurogenetics 5:129-133
14. National Centre for Biotechnology Information, http://www. ncbi.nlm.nih.gov/
15. Sleddens HF, Oostra BA, Brinkmann AO, et al (1992) Trinucleotide repeat polymorphism in the androgen receptor gene (AR). Nucleic Acids Res 20:1427
16. Westberg L, Baghaei F, Rosmond R, et al (2001) Polymorphisms of the androgen receptor gene and the estrogen receptor beta gene are associated with androgen levels in women. J Clin Endocrinol Metab 86:2562-2568
17. Krithivas K, Yurgalevitch SM, Mohr BA, et al (1999) Evidence that the CAG repeat in the androgen receptor gene is associated with the age-related decline in serum androgen levels in men. J Endocrinol 162:137-142
18. Chamberlain NL, Driver ED, Miesfeld RL (1994) The length and location of CAG trinucleotide repeats in the androgen receptor N-terminal domain affect transactivation function. Nucleic Acids Res 22:3181-3186
19. Yong EL, Ghadessy F, Wang Q, et al (1998) Androgen receptor transactivation domain and control of spermatogenesis. Rev Reprod 3:141-144
20. Zitzmann M, Brune M, Kornmann B, et al (2001) The CAG repeat polymorphism in the AR gene affects high density lipoprotein cholesterol and arterial vasoreactivity. J Clin Endocrinol Metab 86:4867-4873
21. Bouchard P (1999) Progesterone and the progesterone receptor. J Reprod Med 44:153-157
22. Bethea CL, Lu NZ, Gundlah C, et al (2002) Diverse actions of ovarian steroids in the serotonin neural system. Front Neuroendocrinol 23:41-100
23. Cenni B, Picard D (1999) Ligand-independent activation of steroid receptors: new roles for old players. Trends Endocrinol Metab 10:41-46
24. Rowe SM, Coughlan SJ, McKenna NJ, et al (1995) Ovarian carcinoma-associated Taq I restriction fragment length polymorphism in intron G of the progesterone receptor gene is due to an Alu sequence insertion. Cancer Res 55:2743-2745
25. Tong D, Fabjani G, Heinze G, et al (2001) Analysis of the human progesterone receptor gene polymorphism progins in Austrian ovarian carcinoma patients. Int J Cancer 95:394-397
26. Runnebaum IB, Wang-Gohrke S, Vesprini D, et al (2001) Progesterone receptor variant increases ovarian cancer risk in BRCA 1 and BRCA 2 mutation carriers who were never exposed to oral contraceptives. Pharmacogenetics 11:635-638
27. Donaldson CJ, Crapanzano JP, Watson JC, et al (2002) PROGINS Alu insertion and human genomic diversity. Mutat Res 501:137-141
28. Lea RA, Curtain RP, Hutchins C, et al (2001) Investigation of the CACNA 1A gene as a candidate for typical migraine susceptibility. Am J Med Genet 105:707-712
29. Johnson MP, Lea RA, Curtain RP, et al (2003) An investigation of the 5-HT2C receptor gene as a migraine candidate gene. Am J Med Genet 117B:86-89
30. Miller SA, Dykes DD, Polesky HF (1988) A simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acids Res 16:1215
31. Lancaster JM, Berchuck A, Carney ME, et al (1998) Progesterone receptor gene polymorphism and risk for breast and ovarian cancer. Br J Cancer 78:277
32. Sham P, Curtis D (1995) Monte Carlo tests for associations between disease and alleles at highly polymorphic loci. Ann Hum Genet 59:97-105
33. Mantel N, Haenszel W (1959) Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 22:719-748
34. Hall JM, Couse JF, Korach KS (2001) The multifaceted mechanisms of estradiol and estrogen receptor signaling. J Biol Chem 276:36869-36872
35. Schumacher M (1990) Rapid membrane effects of steroid hormones: an emerging concept in neuroendocrinology. Trends Neurosci 13:359-362
36. Tan RS, Pu SJ, Culberson JW (2004) Role of androgens in mild cognitive impairment and possible interventions during andropause. Med Hypotheses 62:14-18
37. Lu NZ, Bethea CL (2002) Ovarian steroid regulation of 5-HT1A receptor binding and G protein activation in female monkeys. Neuropsychopharmacology 27:12-24
38. Blomqvist A (2000) Sex hormones and pain: a new role for brain aromatase? J Comp Neurol 423:549-551
39. Kurz C, Tempfer CB, Boecskoer S, et al (2001) The PROGINS progesterone receptor gene polymorphism and idiopathic recurrent miscarriage. J Soc Gynecol Investig 8:295-298